El-Serag, H. B.; Mason, A. C. (1999). „Rising incidence of hepatocellular carcinoma in the United States”. New England Journal of Medicine. 340 (10): 745—50. PMID10072408. doi:10.1056/NEJM199903113401001..
Block, T. M.; Mehta, A. S.; Fimmel, C. J.; Jordan, R. (2003). „Molecular viral oncology of hepa-tocellular carcinoma”. Oncogene. 22 (33): 5093—107. PMID12910247. S2CID36007702. doi:10.1038/sj.onc.1206557..
Shiha G, Ibrahim A, Helmy A, Sarin SK, Omata M, Kumar A, et al. . "Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update". Hepatology International. Shiha, G.; et al. (јануар 2017). „Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: A 2016 update”. Hepatology International. 11 (1): 1—30. PMID27714681. S2CID34896412. doi:10.1007/s12072-016-9760-3.CS1 одржавање: Формат датума (веза).
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. . "The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases" (PDF). Hepatology. Chalasani, N.; Younossi, Z.; Lavine, J. E.; Charlton, M.; Cusi, K.; Rinella, M.; Harrison, S. A.; Brunt, E. M.; Sanyal, A. J. (јануар 2018). „The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases”. Hepatology International. 67 (1): 328—357. PMID28714183. S2CID4120649. doi:10.1002/hep.29367.CS1 одржавање: Формат датума (веза).
Marrero, Jorge A.; Kulik, Laura M.; Sirlin, Claude B.; Zhu, Andrew X.; Finn, Richard S.; Abecassis, Michael M.; Roberts, Lewis R.; Heimbach, Julie K. (2018). „Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases”. Hepatology. 68 (2): 723—750. PMID29624699. S2CID4666537. doi:10.1002/hep.29913.
Hsu, C.; Chen, C. N.; Chen, L. T.; Wu, C. Y.; Yang, P. M.; Lai, M. Y.; Lee, P. H.; Cheng, A. L. (2003). „Low-dose thalidomide treatment for advanced hepatocellular carcinoma”. Oncology. 65 (3): 242—9. PMID14657598. S2CID25528287. doi:10.1159/000074477..
Wigg, A. J.; Palumbo, K.; Wigg, D. R. (2010). „Radiotherapy for hepatocellular carcinoma: Systematic review of radiobiology and modeling projections indicate reconsideration of its use”. Journal of Gastroenterology and Hepatology. 25 (4): 664—671. PMID20074152. S2CID46110083. doi:10.1111/j.1440-1746.2009.06126.x..
Kulik, L. M.; Carr, B. I.; Mulcahy, M. F.; Lewandowski, R. J.; Atassi, B.; Ryu, R. K.; Sato, K. T.; Benson a, 3rd; Nemcek Jr, A. A.; Gates, V. L.; Abecassis, M.; Omary, R. A.; Salem, R. (2008). „Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis”. Hepatology (Baltimore, Md.). 47 (1): 71—81. PMID18027884. S2CID27591331. doi:10.1002/hep.21980..
Fan, Jia; Yang, Guang-Shun; Fu, Zhi-Ren; Peng, Zhi-Hai; Xia, Qiang; Peng, Chen-Hong; Qian, Jian-Ming; Zhou, Jian; Xu, Yang; et al. (2009). „Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China”. Journal of Cancer Research and Clinical Oncology. 135 (10): 1403—1412. PMID19381688. S2CID1216580. doi:10.1007/s00432-009-0584-6.CS1 одржавање: Вишеструка имена: списак аутора (веза).
Vitale, A.; Gringeri, E.; Valmasoni, M.; d'Amico, F.; Carraro, A.; Pauletto, A.; d'Amico, F. J.; Polacco, M.; d'Amico, D. F.; Cillo, U. (2007). „Long-term results of liver transplantation for hepatocellular carcinoma: An update of the University of Padova experience”. Transplantation Proceedings. 39 (6): 1892—1894. PMID17692645. doi:10.1016/j.transproceed.2007.05.031..
El-Serag, H. B.; Mason, A. C. (1999). „Rising incidence of hepatocellular carcinoma in the United States”. New England Journal of Medicine. 340 (10): 745—50. PMID10072408. doi:10.1056/NEJM199903113401001..
Block, T. M.; Mehta, A. S.; Fimmel, C. J.; Jordan, R. (2003). „Molecular viral oncology of hepa-tocellular carcinoma”. Oncogene. 22 (33): 5093—107. PMID12910247. S2CID36007702. doi:10.1038/sj.onc.1206557..
Shiha G, Ibrahim A, Helmy A, Sarin SK, Omata M, Kumar A, et al. . "Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update". Hepatology International. Shiha, G.; et al. (јануар 2017). „Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: A 2016 update”. Hepatology International. 11 (1): 1—30. PMID27714681. S2CID34896412. doi:10.1007/s12072-016-9760-3.CS1 одржавање: Формат датума (веза).
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. . "The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases" (PDF). Hepatology. Chalasani, N.; Younossi, Z.; Lavine, J. E.; Charlton, M.; Cusi, K.; Rinella, M.; Harrison, S. A.; Brunt, E. M.; Sanyal, A. J. (јануар 2018). „The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases”. Hepatology International. 67 (1): 328—357. PMID28714183. S2CID4120649. doi:10.1002/hep.29367.CS1 одржавање: Формат датума (веза).
Marrero, Jorge A.; Kulik, Laura M.; Sirlin, Claude B.; Zhu, Andrew X.; Finn, Richard S.; Abecassis, Michael M.; Roberts, Lewis R.; Heimbach, Julie K. (2018). „Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases”. Hepatology. 68 (2): 723—750. PMID29624699. S2CID4666537. doi:10.1002/hep.29913.
Hsu, C.; Chen, C. N.; Chen, L. T.; Wu, C. Y.; Yang, P. M.; Lai, M. Y.; Lee, P. H.; Cheng, A. L. (2003). „Low-dose thalidomide treatment for advanced hepatocellular carcinoma”. Oncology. 65 (3): 242—9. PMID14657598. S2CID25528287. doi:10.1159/000074477..
Wigg, A. J.; Palumbo, K.; Wigg, D. R. (2010). „Radiotherapy for hepatocellular carcinoma: Systematic review of radiobiology and modeling projections indicate reconsideration of its use”. Journal of Gastroenterology and Hepatology. 25 (4): 664—671. PMID20074152. S2CID46110083. doi:10.1111/j.1440-1746.2009.06126.x..
Kulik, L. M.; Carr, B. I.; Mulcahy, M. F.; Lewandowski, R. J.; Atassi, B.; Ryu, R. K.; Sato, K. T.; Benson a, 3rd; Nemcek Jr, A. A.; Gates, V. L.; Abecassis, M.; Omary, R. A.; Salem, R. (2008). „Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis”. Hepatology (Baltimore, Md.). 47 (1): 71—81. PMID18027884. S2CID27591331. doi:10.1002/hep.21980..
Fan, Jia; Yang, Guang-Shun; Fu, Zhi-Ren; Peng, Zhi-Hai; Xia, Qiang; Peng, Chen-Hong; Qian, Jian-Ming; Zhou, Jian; Xu, Yang; et al. (2009). „Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China”. Journal of Cancer Research and Clinical Oncology. 135 (10): 1403—1412. PMID19381688. S2CID1216580. doi:10.1007/s00432-009-0584-6.CS1 одржавање: Вишеструка имена: списак аутора (веза).
Vitale, A.; Gringeri, E.; Valmasoni, M.; d'Amico, F.; Carraro, A.; Pauletto, A.; d'Amico, F. J.; Polacco, M.; d'Amico, D. F.; Cillo, U. (2007). „Long-term results of liver transplantation for hepatocellular carcinoma: An update of the University of Padova experience”. Transplantation Proceedings. 39 (6): 1892—1894. PMID17692645. doi:10.1016/j.transproceed.2007.05.031..
Block, T. M.; Mehta, A. S.; Fimmel, C. J.; Jordan, R. (2003). „Molecular viral oncology of hepa-tocellular carcinoma”. Oncogene. 22 (33): 5093—107. PMID12910247. S2CID36007702. doi:10.1038/sj.onc.1206557..
Shiha G, Ibrahim A, Helmy A, Sarin SK, Omata M, Kumar A, et al. . "Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update". Hepatology International. Shiha, G.; et al. (јануар 2017). „Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: A 2016 update”. Hepatology International. 11 (1): 1—30. PMID27714681. S2CID34896412. doi:10.1007/s12072-016-9760-3.CS1 одржавање: Формат датума (веза).
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. . "The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases" (PDF). Hepatology. Chalasani, N.; Younossi, Z.; Lavine, J. E.; Charlton, M.; Cusi, K.; Rinella, M.; Harrison, S. A.; Brunt, E. M.; Sanyal, A. J. (јануар 2018). „The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases”. Hepatology International. 67 (1): 328—357. PMID28714183. S2CID4120649. doi:10.1002/hep.29367.CS1 одржавање: Формат датума (веза).
Marrero, Jorge A.; Kulik, Laura M.; Sirlin, Claude B.; Zhu, Andrew X.; Finn, Richard S.; Abecassis, Michael M.; Roberts, Lewis R.; Heimbach, Julie K. (2018). „Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases”. Hepatology. 68 (2): 723—750. PMID29624699. S2CID4666537. doi:10.1002/hep.29913.
Hsu, C.; Chen, C. N.; Chen, L. T.; Wu, C. Y.; Yang, P. M.; Lai, M. Y.; Lee, P. H.; Cheng, A. L. (2003). „Low-dose thalidomide treatment for advanced hepatocellular carcinoma”. Oncology. 65 (3): 242—9. PMID14657598. S2CID25528287. doi:10.1159/000074477..
Wigg, A. J.; Palumbo, K.; Wigg, D. R. (2010). „Radiotherapy for hepatocellular carcinoma: Systematic review of radiobiology and modeling projections indicate reconsideration of its use”. Journal of Gastroenterology and Hepatology. 25 (4): 664—671. PMID20074152. S2CID46110083. doi:10.1111/j.1440-1746.2009.06126.x..
Kulik, L. M.; Carr, B. I.; Mulcahy, M. F.; Lewandowski, R. J.; Atassi, B.; Ryu, R. K.; Sato, K. T.; Benson a, 3rd; Nemcek Jr, A. A.; Gates, V. L.; Abecassis, M.; Omary, R. A.; Salem, R. (2008). „Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis”. Hepatology (Baltimore, Md.). 47 (1): 71—81. PMID18027884. S2CID27591331. doi:10.1002/hep.21980..
Fan, Jia; Yang, Guang-Shun; Fu, Zhi-Ren; Peng, Zhi-Hai; Xia, Qiang; Peng, Chen-Hong; Qian, Jian-Ming; Zhou, Jian; Xu, Yang; et al. (2009). „Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China”. Journal of Cancer Research and Clinical Oncology. 135 (10): 1403—1412. PMID19381688. S2CID1216580. doi:10.1007/s00432-009-0584-6.CS1 одржавање: Вишеструка имена: списак аутора (веза).
Michelakos, T; Xourafas, D; Qadan, M; Pieretti-Vanmarcke, R; Cai, L; Patel, MS; Adler, JT; Fontan, F; Basit, U; Vagefi, PA; Elias, N; Tanabe, KK; Berger, D; Yeh, H; Markmann, JF; Chang, DC; Ferrone, CR (јун 2019). „Hepatocellular Carcinoma in Transplantable Child-Pugh A Cirrhotics: Should Cost Affect Resection vs Transplantation?”. Journal of Gastrointestinal Surgery. 23 (6): 1135—1142. PMID30218342. S2CID52275656. doi:10.1007/s11605-018-3946-z.CS1 одржавање: Вишеструка имена: списак аутора (веза)CS1 одржавање: Формат датума (веза).